Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

R&D? S&D? It’s About Science

Posted on February 9th, 2016 by in Pharma R&D

Last month’s announcement that industry giants AstraZeneca, GSK, and Johnson & Johnson had teamed up with three well-regarded UK universities –Imperial College London, University College London, and University of Continue reading “R&D? S&D? It’s About Science” »

Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?

Posted on January 12th, 2016 by in Pharma R&D

It’s the turn of the year and if you’re like me, you’ve been immersed in reading all of the accompanying look back and look ahead articles and reports. 2015 was, indeed, a notable year — from the Martin Shkreli fiasco to the proposed Pfizer and Allergan merger — the industry was rocked. Continue reading “Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?” »